sotorasib,docetaxel
amgen,sanofi,aventis
['codebreak 200', 'docetaxel']
 many drugs targeting kras are currently tested. among which 4 are tested in phase 3 trial (vs docetaxel). codebreak 200 to be released on monday #esmo22. great overview by 
MD, PhD, Prof of Respiratory Medicine, Thoracic Oncology Specialist @CHUdeToulouse, @IUCTOncopoleICR; Researcher, INSERM @crctoncopole #LCSM ????? ?? ??